Skip to main content
Erschienen in: Journal of Neurology 6/2020

Open Access 04.03.2020 | Neurological Update

Neurological update: dizziness

verfasst von: Diego Kaski

Erschienen in: Journal of Neurology | Ausgabe 6/2020

Abstract

The diagnosis and management of vertigo remains a challenge for clinicians, including general neurology. In recent years there have been advances in the understanding of established vestibular syndromes, and the development of treatments for existing vestibular diagnoses. In this ‘update’ I will review how our understanding of previously “unexplained” dizziness in the elderly is changing, explore novel insights into the pathophysiology of vestibular migraine, and its relationship to the newly coined term ‘persistent postural perceptual dizziness’, and finally discuss how a simple bedside oculomotor assessment may help identify vestibular presentations of stroke.

Introduction

The world of dizziness has experienced a dramatic change over the last 3 decades, as new treatable syndromes have been identified, and novel treatments developed for existing vestibular diagnoses. Despite such progress, many clinicians, including neurologists, admit to a lack of confidence in the diagnosis and management of the dizzy patient, leading to circuitous patient journeys, from one specialty to another. Most emergency and primary care ‘dizzy’ referrals in the UK are fielded to ENT surgeons, a departure from neuro towards otology, although it could be argued that vertigo is a neurological symptom, a cortically driven percept, irrespective of the causative insult.
One common challenge in the field is elderly patients reporting a vague sense of dizziness and imbalance, who as a result of normal audiovestibular testing, remain “unexplained”. I will review recent evidence suggesting possible mechanisms relating to small vessel disease that may contribute to this syndrome. Whilst new variants of benign paroxysmal positional vertigo (BPPV) have been recently described [1], the Epley and Semont treatment manoeuvres for the commonest type of BPPV are still not universally employed by neurologists [2], and BPPV remains under-diagnosed, and under-treated. The commonest differential diagnosis for BPPV is vestibular migraine, a condition that is increasingly recognised outside specialist centres, but remains under-diagnosed. Here, I review the most recent advances in vestibular migraine (VM) diagnosis and treatment. VM in turn is a common precursor to a more chronic form of dizziness recently renamed persistent postural perceptual dizziness (PPPD), and there has been a growth in the unravelling of the neurobiology of this disorder. Finally, vestibular neurology is rich in clinical bedside skills; indeed, an evaluation of eye movements may more precisely identify and localise a stroke than state-of-the-art imaging [3]. I describe and review the use and utility of the HINTS examination in stroke.

“Unexplained” dizziness in the elderly

The symptom complex of subjective unsteadiness and a persistent sensation of light-headedness, without any rotational vertigo—that patients refer to as a vague sense of “dizziness”—is often reported by elderly patients attending neurology or balance clinics [4]. In light of a normal extensive battery of neurological and neuro-otological assessments, the patient’s dizziness may be termed “unexplained”, a particularly common and challenging problem in the elderly.
Cerebral small vessel disease (cSVD) is associated with a range of radiological findings, including white matter hyperintensities in the cerebral white matter on proton density-weighted, T2-weighted and fluid attenuated inversion recovery (FLAIR) MR images, considered to be vascular in origin [5, 6]. cSVD is a common finding in the ageing population, present in 10% of patients in their 70s and increases to 85% in the 90s [7]. Despite the established association between cSVD and gait disturbance, most large-scale studies of cSVD have, perhaps surprisingly, not reported on the presence (or absence) of dizziness symptoms in these patients. A prospective study of 26 older patients (> 75 years of age) with disequilibrium of unknown cause, found that in 12 cases they had a degree of MRI cSVD that correlated with poorer performance on objective measures of balance and frequency of falls [8]. In a subsequent longitudinal study with yearly examinations in 59 older subjects, Baloh et al. again found a higher correlation between white matter hyperintensities on MRI and changes in stance and gait [9].
Ahmad et al. sub-divided patients with cSVD into either ‘high’ or ‘low’ cSVD burden and identified that over 80% patients with high grades of cSVD suffered from otherwise unexplained dizziness, compared to 48% of patients with low-grade cSVD [4].The implication is that cSVD may be an independent factor in the development of balance and dizziness symptoms in the elderly.
Recently we proposed a theoretic framework for “unexplained” dizziness in the elderly whereby a central disturbance of vestibular processing and integration results from cSVD-related cortico-subcortical and cortico-cortical dysfunction (Fig. 1) [10]. In addition, hemodynamic changes in the blood flow within the white matter due to small vessel disease, in combination with cerebral postural hypotension, has been hypothesised to contribute to the postural lightheadedness in this condition (Fig. 1) [10]. This has been corroborated by electroencephalographic changes during postural challenges between elderly individuals with and without “unexplained” dizziness, partly driven by the presence of cSVD (Ibitoye R et al. manuscript in preparation). Further work is underway to explore the mechanisms by which cSVD may contribute to postural instability in the elderly, perhaps helping to identify novel treatment avenues targeting cortical excitability [11].

Vestibular migraine

As arguably the most common neurological disorder, migraine affects approximately 15% of the general population [12], and although dizziness is also a common symptom in the general population [13], several studies have found a close association between dizziness and migraine beyond what one might expect through chance [1416], suggesting a pathological link between migraine and dizziness [17]. Vestibular migraine (VM) is perhaps less-well recognised outside specialist vestibular clinics [18]. Indeed, although VM has recently been included in the third edition of the International Classification of Headache Disorders (ICHD-3) (Box 1), it is currently listed as an appendix [19], indicating the need for further validation with high-level evidence, which may lead to its formal acceptance in future revisions.
Box 1
Bárány Society diagnostic criteria for persistent postural perceptual dizziness
(A) One or more symptoms of dizziness, unsteadiness or non-spinning vertigo on most days for at least 3 months
Symptoms last for prolonged (hours-long) periods of time, but may wax and wane in severity
Symptoms need not be present continuously throughout the entire day
(B) Persistent symptoms occur without specific provocation, but are exacerbated by three factors: upright posture, active or passive motion without regard to direction or position, and exposure to moving visual stimuli or complex visual patterns
(C) The disorder is triggered by events that cause vertigo, unsteadiness, dizziness, or problems with balance, including acute, episodic or chronic vestibular syndromes, other neurological or medical illnesses, and psychological distress
  When triggered by an acute or episodic precipitant, symptoms settle into the pattern of criterion A as the precipitant resolves, but may occur intermittently at first, and then consolidate into a persistent course
  When triggered by a chronic precipitant, symptoms may develop slowly at first and worsen gradually
(D) Symptoms cause significant distress or functional impairment
(E) Symptoms are not better accounted for by another disease or disorder
Patients with VM experience episodic vestibular symptoms and migrainous features (nausea, photophobia, phonophobia, motion intolerance, catamenial association), with or without concurrent headache. They frequently report sensitivity to head motion and visual surroundings or disabling misperceptions such as a sudden imbalance or body tilt [20]. Clinical pearls that suggest VM include a pre-existing history of motion sickness, and particularly being unable to read in the passenger seat of a car due to nausea, and a discomfort during upgaze with the eye movement assessment. There may be central eye movement signs during an acute episode [21], but the examination is typically normal inter-ictally [19].
At a molecular level, there appears to a differential proinflammatory signature (namely IL-1β, CCL3, CCL22, and CXCL1 levels) capable of differentiating VM patients from patients with Meniere’s Disease, conditions that can overlap clinically [22]. Whether such pro-inflammatory markers are capable of segregating typical migraine from VM remains to be seen.
Neurophysiological findings do however suggest a specific abnormality of visuo-vestibular interaction as a pathophysiological mechanism in VM; for example, patients with VM have a longer duration of post-rotatory nystagmus compared with healthy controls or migraine patients without dizziness [23]. We have identified abnormally elevated reflexive and perceptual vestibular thresholds at baseline in vestibular migraine patients [24]. Following visual motion exposure, both reflex and perceptual thresholds were further increased in vestibular migraine patients relative to healthy controls, migraineurs without vestibular symptoms and patients with benign paroxysmal positional vertigo [24]. This supports the notion of specific altered visuo-vestibular cortical interactions in vestibular migraine. This notion is further supported by imaging studies in VM patients revealing structural and functional changes within the temporo-parietal regions [25, 26]-areas involved in sensory integration for coherent spatial perception [27, 28].
Further molecular, imaging, and neurophysiological studies are needed to better define the pathogenic signatures of vestibular migraine. Better understanding of symptoms related to visuo-vestibular integration in VM, such as tilt sensitivity, upright misperception [29], and ictal nystagmus [21] may provide further pathophysiological clues to this condition.
As for other types of migraine, both abortive and preventive medications have been used in VM patients. However, large-scale randomized placebo-controlled clinical trials in VM are missing, although a prospective randomized non-placebo-controlled study in VM patients suggested flunarizine is effective in decreasing the severity and frequency of vertigo attacks [30]. Table 1 summarises studies on preventive treatments for vestibular migraine. Life-style adjustment, trigger avoidance and vestibular rehabilitation are also shown to be beneficial in VM patients, where secondary psychological factors may also play a role in disease burden.
Table 1
Summary of studies on preventive treatments for vestibular migraine defined based on the ICHD-3 criteria.
(from [20])
Drug
Daily dose
Study design
Duration
Outcome
 
Propranolol*
40–160 mg
33 patients, prospective, randomized, controlled
4 months
Severity: DHI 55.8 ± 2.7 to 31.3 ± 3.7*
VSS 7.3 ± 0.3 to 2.1 ± 0.4* Attacks per month: 12.6 ± 1.8 to 1.9 ± 0.7
Salviz et al. [31] (158)
Venlafaxine
37.5–150 mg
31 patients, prospective, randomized, controlled
4 months
Severity: DHI 50.9 ± 2.5 to 19.9 ± 2.9*
VSS 7.1 ± 0.3 to 1.8 ± 0.5* Attacks per month: 12.2 ± 1.8 to 2.6 ± 1.1 *
Salviz et al. [31] (158)
Venlafaxine
37.5 mg
25 patients, prospective
3 months
Severity: DHI 41.7 ± 16.9 to 31.3 ± 14.1*
VSS 5.9 ± 1.7 to 3.8 ± 1.2*
Liu et al. [32] (157)
Flunarizine
10 mg
25 patients, prospective
3 months
Severity: DHI 46.6 ± 15.1 to 39.8 ± 16.3*
VSS 6.4 ± 1 .9 to 5.9 ± 1.6*
Liu et al. [32] (157)
Valproic acid
1000 mg
25 patients, prospective
3 months
Severity: DHI 46.8 ± 13.5 to 38.7 ± 13.6*
VSS 5.8 ± 1.8 to 5.3 ± 1.0
Liu et al. [32] (157)
Cinnarizine
75 mg
24 patients, retrospective open-label
3 months
Attacks per month: 3.8 ± 1.1 to 0.4 ± 0.6*
Taghdiri et al. [33] (160)
DHI Dizziness handicap inventory, VSS Vertigo Severity score (Liu et al.)
*p < 0.05

Persistent postural perceptual dizziness

Persistent postural perceptual dizziness is characterised by persistent dizziness and perceived instability, worse in the upright position and in busy visual environments [34]. An acute episode of dizziness may precede these symptoms, and the disorder will usually emerge with resolution of the triggering event. The most common precipitants are central or peripheral vestibular disorders such as BPPV (25%) and episodes of vestibular migraine (VM) (20%), with head trauma, panic attack and generalised anxiety disorders each accounting for a further 15% [34].
The Bárány Society have set out diagnostic criteria (Box 1) [35] reliant upon a thorough clinical history. Like many other functional neurological symptoms, PPPD is not a diagnosis of exclusion, although physical, neurophysiological, biochemical and radiological investigation may be required to fully explore alternative differentials. The clinician must be mindful that PPPD can co-occur with structural vestibular and other neurological disorders. For example, a patient with VM may develop PPPD with acute vertiginous episodes (VM) on a background of persistent dizziness (PPPD) [36].
Whilst the pathophysiology of functional vestibular disorders such as PPPD is not yet clear, normal physiological and behavioural responses to an acute postural threat appear to become inappropriately sustained after remission of the acute event [34]. Patients who develop PPPD after an acute event show persistent high visual dependence (an over-reliance on vision for balance), high anxiety and hypervigilance to balance sensations compared with those who recover well after an acute vestibular insult [37]. Prior anxiety and neurotic personality (state and trait anxiety) appear to predispose to this maladaptation [38].
Maladaptive behaviours in PPPD likely relate to heightened sensitivity to minor discrepancies between anticipated and actual afferent postural signals. This results in greater attention and effort to actively maintain balance, in turn feeding hypervigilance and reliance on ‘high-risk’ strategies. The misperceived discrepancy between predicted and actual risk becomes reinforced and a vicious cycle is established, leading to a ‘scaling mismatch’ between actual and perceived postural movements. Normal balance can be restored temporarily with distraction (e.g. performing a cognitive task during Romberg stance), which can therefore be used therapeutically in rehabilitation [34].
Neuroimaging studies in turn have demonstrated that activity and connectivity in brain regions that process visual, vestibular and spatial information differ between individuals with and without PPPD. A failure of top-down cortical network suppression of ascending postural information may result in persistence of the acute, high-risk postural behaviour [38].
Whether a top-down, or bottom-up disorder, from a practical perspective, it is important to explain to patients that PPPD is a common cause of chronic dizziness that can be treated successfully. It may also be valuable to demonstrate the reversibility of some symptoms using distraction techniques during physical examination. Treatment options include: (1) vestibular and balance physiotherapy, with the aim of reducing visual dependence and desensitising the balance system, (2) medications, including Amitriptyline and Sertraline [39], and (3) cognitive behavioural therapy (CBT) to reduce hypervigilance and anxiety, and related behaviours [40]. Combination of these three interventions using a “cognitive physiotherapy” approach is recommended, at the earliest possible stage.

Dizziness and stroke

Identifying stroke in a patient with acute vertigo is challenging particularly in the absence of accompanying neurological symptoms and signs. This is particularly true of strokes in the hyperacute phase and small strokes that may escape detection on imaging [3]. Small strokes causing isolated vertigo therefore carry a higher chance of misdiagnosis in the emergency setting, even more so as they escape the Face Arm Speech Time (FAST) stroke symptoms.
The HINTS-plus (Head Impulse, direction-changing Nystagmus, and a Test of Skew, plus a bedside assessment of hearing) examination can be used to help identify posterior circulation stroke in patients with prolonged acute vertigo and one or more risk factors for stroke. In one study, this is 100% sensitive and 96% specific for posterior circulation stroke [3]. Although the implementation of HINTS-plus evaluation in the ED may be valuable and feasible for neurologists, it poses a significant challenge for emergency physicians, with only a 9% take-up rate following a 2-month implementation program [41]. Thus, its value in the primary care setting is uncertain. Application of artificial intelligence and tele-consultation [42], incorporating a structured oculomotor assessment, and perhaps including vascular/perfusion imaging for isolated vestibular syndromes, may be future perspectives for real-time decision making in acute dizziness and vertigo.

Conclusions

The field of vestibular science continues to make advances into the twenty-first century, with current priorities being the introduction and expansion of vestibular neurology into undergraduate medical curricula, to improve clinical diagnosis of patients with vertigo in acute, primary, and secondary care, encouragement of large-scale randomised controlled clinical trials for vestibular migraine, improved understanding of the mechanisms leading to chronic dizziness (PPPD), and exploration of how multiple factors, including cSVD, may contribute to otherwise “unexplained” dizziness in the elderly.

Compliance with ethical standards

Conflicts of interest

The corresponding author states that there is no conflict of interest.

Human and animal rights statement

The manuscript does not contain clinical studies or patient data.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Büki B, Mandalà M, Nuti D (2014) Typical and atypical benign paroxysmal positional vertigo: literature review and new theoretical considerations. J Vestib Res Equilib Orientat 24(5 6):415–423CrossRef Büki B, Mandalà M, Nuti D (2014) Typical and atypical benign paroxysmal positional vertigo: literature review and new theoretical considerations. J Vestib Res Equilib Orientat 24(5 6):415–423CrossRef
2.
Zurück zum Zitat Ulytė A, Valančius D, Masiliūnas R, Paškonienė A, Lesinskas E, Kaski D et al (2019) Diagnosis and treatment choices of suspected benign paroxysmal positional vertigo: current approach of general practitioners, neurologists, and ENT physicians. Eur Arch Oto-Rhino-Laryngol 276(4):985–991CrossRef Ulytė A, Valančius D, Masiliūnas R, Paškonienė A, Lesinskas E, Kaski D et al (2019) Diagnosis and treatment choices of suspected benign paroxysmal positional vertigo: current approach of general practitioners, neurologists, and ENT physicians. Eur Arch Oto-Rhino-Laryngol 276(4):985–991CrossRef
3.
Zurück zum Zitat Kattah JC, Talkad AV, Wang DZ, Hsieh Y-H, Newman-Toker DE (2009) HINTS to diagnose stroke in the acute vestibular syndrome. Stroke 40:3504–3510CrossRef Kattah JC, Talkad AV, Wang DZ, Hsieh Y-H, Newman-Toker DE (2009) HINTS to diagnose stroke in the acute vestibular syndrome. Stroke 40:3504–3510CrossRef
4.
Zurück zum Zitat Ahmad H, Cerchiai N, Mancuso M, Casani AP, Bronstein AM (2015) Are white matter abnormalities associated with “unexplained dizziness”? J Neurol Sci 358:428–431CrossRef Ahmad H, Cerchiai N, Mancuso M, Casani AP, Bronstein AM (2015) Are white matter abnormalities associated with “unexplained dizziness”? J Neurol Sci 358:428–431CrossRef
5.
Zurück zum Zitat The LADIS Study Group, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J et al (2011) 2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 32:577–588CrossRef The LADIS Study Group, Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J et al (2011) 2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 32:577–588CrossRef
6.
Zurück zum Zitat Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF (2019) CNS small vessel disease. Neurology 92(24):1146–1156CrossRef Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF (2019) CNS small vessel disease. Neurology 92(24):1146–1156CrossRef
7.
Zurück zum Zitat Wardlaw JM, Smith C, Dichgans M (2013) Mechanisms of sporadic cerebral small vessel disease Insights from neuroimaging. Lancet Neurol 12(5):483–497CrossRef Wardlaw JM, Smith C, Dichgans M (2013) Mechanisms of sporadic cerebral small vessel disease Insights from neuroimaging. Lancet Neurol 12(5):483–497CrossRef
8.
Zurück zum Zitat Fife TD, Baloh RW (1993) Disequilibrium of unknown cause in older people. Ann Neurol 34:694–702CrossRef Fife TD, Baloh RW (1993) Disequilibrium of unknown cause in older people. Ann Neurol 34:694–702CrossRef
9.
Zurück zum Zitat Baloh RW, Ying SH, Jacobson KM (2003) A longitudinal study of gait and balance dysfunction in normal older people. Arch Neurol 60:835CrossRef Baloh RW, Ying SH, Jacobson KM (2003) A longitudinal study of gait and balance dysfunction in normal older people. Arch Neurol 60:835CrossRef
10.
Zurück zum Zitat Kaski D, Rust HM, Ibitoye R, Arshad Q, Allum JHJ, Bronstein AM (2019) Theoretical framework for “unexplained” dizziness in the elderly: The role of small vessel disease. Prog Brain Res 248:225–240CrossRef Kaski D, Rust HM, Ibitoye R, Arshad Q, Allum JHJ, Bronstein AM (2019) Theoretical framework for “unexplained” dizziness in the elderly: The role of small vessel disease. Prog Brain Res 248:225–240CrossRef
11.
Zurück zum Zitat Kaski D, Dominguez RO, Allum JH, Bronstein AM (2013) Improving gait and balance in patients with leukoaraiosis using transcranial direct current stimulation and physical training: an exploratory study. Neurorehabil Neural Repair 27:864–871CrossRef Kaski D, Dominguez RO, Allum JH, Bronstein AM (2013) Improving gait and balance in patients with leukoaraiosis using transcranial direct current stimulation and physical training: an exploratory study. Neurorehabil Neural Repair 27:864–871CrossRef
12.
Zurück zum Zitat Feigin VL, Krishnamurthi RV, Theadom AM, Abajobir AA, Mishra SR, Ahmed MB et al (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16(11):877–897CrossRef Feigin VL, Krishnamurthi RV, Theadom AM, Abajobir AA, Mishra SR, Ahmed MB et al (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16(11):877–897CrossRef
13.
Zurück zum Zitat Bösner S, Schwarm S, Grevenrath P, Schmidt L, Hörner K, Beidatsch D et al (2018) Prevalence, aetiologies and prognosis of the symptom dizziness in primary care—a systematic review. BMC Fam Pract 19(1):33CrossRef Bösner S, Schwarm S, Grevenrath P, Schmidt L, Hörner K, Beidatsch D et al (2018) Prevalence, aetiologies and prognosis of the symptom dizziness in primary care—a systematic review. BMC Fam Pract 19(1):33CrossRef
14.
Zurück zum Zitat Calhoun AH, Ford S, Pruitt AP, Fisher KG (2011) The point prevalence of dizziness or vertigo in migraine—and factors that influence presentation. Headache 51(9):1388–1392CrossRef Calhoun AH, Ford S, Pruitt AP, Fisher KG (2011) The point prevalence of dizziness or vertigo in migraine—and factors that influence presentation. Headache 51(9):1388–1392CrossRef
15.
Zurück zum Zitat Dieterich M, Brandt T (1999) Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 246(10):883–892CrossRef Dieterich M, Brandt T (1999) Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 246(10):883–892CrossRef
16.
Zurück zum Zitat Neuhauser H, Leopold M, Von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56(4):436–441CrossRef Neuhauser H, Leopold M, Von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56(4):436–441CrossRef
17.
Zurück zum Zitat Eggers SDZ, Staab JP, Neff BA, Goulson AM, Carlson ML, Shepard NT (2011) Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities. Otol Neurotol 32(7):1144–1151CrossRef Eggers SDZ, Staab JP, Neff BA, Goulson AM, Carlson ML, Shepard NT (2011) Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities. Otol Neurotol 32(7):1144–1151CrossRef
18.
Zurück zum Zitat Li V, McArdle H, Trip SA (2019) Vestibular migraine. BMJ [Internet]. 366:l4213CrossRef Li V, McArdle H, Trip SA (2019) Vestibular migraine. BMJ [Internet]. 366:l4213CrossRef
19.
Zurück zum Zitat von Brevern M, Lempert T (2016) Vestibular migraine. Handb Clin Neurol 137:301–316CrossRef von Brevern M, Lempert T (2016) Vestibular migraine. Handb Clin Neurol 137:301–316CrossRef
21.
Zurück zum Zitat Polensek SH, Tusa RJ (2010) Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurotol 15(4):241–246CrossRef Polensek SH, Tusa RJ (2010) Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurotol 15(4):241–246CrossRef
22.
Zurück zum Zitat Flook M, Frejo L, Gallego-Martinez A, Martin-Sanz E, Rossi-Izquierdo M, Amor-Dorado JC et al (2019) Differential proinflammatory signature in vestibular migraine and meniere disease. Front Immunol 10:1229CrossRef Flook M, Frejo L, Gallego-Martinez A, Martin-Sanz E, Rossi-Izquierdo M, Amor-Dorado JC et al (2019) Differential proinflammatory signature in vestibular migraine and meniere disease. Front Immunol 10:1229CrossRef
23.
Zurück zum Zitat Jeong SH, Oh SY, Kim HJ, Koo JW, Kim JS (2010) Vestibular dysfunction in migraine: effects of associated vertigo and motion sickness. J Neurol 257(6):905–912CrossRef Jeong SH, Oh SY, Kim HJ, Koo JW, Kim JS (2010) Vestibular dysfunction in migraine: effects of associated vertigo and motion sickness. J Neurol 257(6):905–912CrossRef
24.
Zurück zum Zitat Bednarczuk NF, Bonsu A, Ortega MC, Fluri AS, Chan J, Rust H et al (2019) Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study. Brain 142(3):606–616CrossRef Bednarczuk NF, Bonsu A, Ortega MC, Fluri AS, Chan J, Rust H et al (2019) Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study. Brain 142(3):606–616CrossRef
25.
Zurück zum Zitat Shin JH, Kim YK, Kim HJ, Kim JS (2014) Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia 34(1):58–67CrossRef Shin JH, Kim YK, Kim HJ, Kim JS (2014) Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia 34(1):58–67CrossRef
26.
Zurück zum Zitat Demarquay G, Ducros A, Montavont A, Mauguiere F (2018) Migraine with brainstem aura: Why not a cortical origin? Cephalalgia 38(10):1687–1695CrossRef Demarquay G, Ducros A, Montavont A, Mauguiere F (2018) Migraine with brainstem aura: Why not a cortical origin? Cephalalgia 38(10):1687–1695CrossRef
27.
Zurück zum Zitat Kheradmand A, Winnick A (2017) Perception of upright: Multisensory convergence and the role of temporo-parietal cortex. Front Neurol 8:552CrossRef Kheradmand A, Winnick A (2017) Perception of upright: Multisensory convergence and the role of temporo-parietal cortex. Front Neurol 8:552CrossRef
28.
Zurück zum Zitat Kaski D, Quadir S, Nigmatullina Y, Malhotra PA, Bronstein AM, Seemungal BM (2016) Temporoparietal encoding of space and time during vestibular-guided orientation. Brain 139(2):392–403CrossRef Kaski D, Quadir S, Nigmatullina Y, Malhotra PA, Bronstein AM, Seemungal BM (2016) Temporoparietal encoding of space and time during vestibular-guided orientation. Brain 139(2):392–403CrossRef
29.
Zurück zum Zitat Winnick A, Sadeghpour S, Otero-Millan J, Chang T-P, Kheradmand A (2018) Errors of upright perception in patients with vestibular migraine. Front Neurol 9:892CrossRef Winnick A, Sadeghpour S, Otero-Millan J, Chang T-P, Kheradmand A (2018) Errors of upright perception in patients with vestibular migraine. Front Neurol 9:892CrossRef
30.
Zurück zum Zitat Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A (2014) Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Oto-Rhino-Laryngol 271(11):2931–2936CrossRef Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A (2014) Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Oto-Rhino-Laryngol 271(11):2931–2936CrossRef
31.
Zurück zum Zitat Salviz M, Yuce T, Acar H et al (2016) Propranolol and venlaf axine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope 126:169–174CrossRef Salviz M, Yuce T, Acar H et al (2016) Propranolol and venlaf axine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope 126:169–174CrossRef
32.
Zurück zum Zitat Liu F, Ma T, Che X et al (2017) The efficacy of venlafaxine, flun arizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol 8:524CrossRef Liu F, Ma T, Che X et al (2017) The efficacy of venlafaxine, flun arizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol 8:524CrossRef
33.
Zurück zum Zitat Taghdiri F, Togha M, Razeghi Jahromi S et al (2014) Cinn arizine for the prophylaxis of migraine associated vertigo: a retrospective study. SpringerPlus 3:231CrossRef Taghdiri F, Togha M, Razeghi Jahromi S et al (2014) Cinn arizine for the prophylaxis of migraine associated vertigo: a retrospective study. SpringerPlus 3:231CrossRef
34.
Zurück zum Zitat Popkirov S, Staab JP, Stone J (2018) Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness. Pract Neurol 18(1):5–13CrossRef Popkirov S, Staab JP, Stone J (2018) Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness. Pract Neurol 18(1):5–13CrossRef
35.
Zurück zum Zitat Staab JP, Eckhardt-Henn A, Horii A, Jacob R, Strupp M, Brandt T et al (2017) Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the classification of vestibular disorders of the Barany Society. J Vestib Res Equilib Orientat 27(4):191–208CrossRef Staab JP, Eckhardt-Henn A, Horii A, Jacob R, Strupp M, Brandt T et al (2017) Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the classification of vestibular disorders of the Barany Society. J Vestib Res Equilib Orientat 27(4):191–208CrossRef
37.
Zurück zum Zitat Cousins S, Kaski D, Cutfield N, Arshad Q, Ahmad H, Gresty MA et al (2017) Predictors of clinical recovery from vestibular neuritis: a prospective study. Ann Clin Transl Neurol 4(5):340–346CrossRef Cousins S, Kaski D, Cutfield N, Arshad Q, Ahmad H, Gresty MA et al (2017) Predictors of clinical recovery from vestibular neuritis: a prospective study. Ann Clin Transl Neurol 4(5):340–346CrossRef
38.
Zurück zum Zitat Dieterich M, Staab JP (2017) Functional dizziness. Curr Opin Neurol 30:107–113CrossRef Dieterich M, Staab JP (2017) Functional dizziness. Curr Opin Neurol 30:107–113CrossRef
40.
Zurück zum Zitat Popkirov S, Stone J, Holle-Lee D (2018) Treatment of persistent postural-perceptual dizziness (PPPD) and related disorders. Curr Treat Options Neurol 20(12):50CrossRef Popkirov S, Stone J, Holle-Lee D (2018) Treatment of persistent postural-perceptual dizziness (PPPD) and related disorders. Curr Treat Options Neurol 20(12):50CrossRef
41.
Zurück zum Zitat Dumitrascu OM, Torbati S, Tighiouart M, Newman-Toker DE, Song SS (2017) Pitfalls and rewards for implementing ocular motor testing in acute vestibular syndrome. Neurologist 22:44–47CrossRef Dumitrascu OM, Torbati S, Tighiouart M, Newman-Toker DE, Song SS (2017) Pitfalls and rewards for implementing ocular motor testing in acute vestibular syndrome. Neurologist 22:44–47CrossRef
42.
Zurück zum Zitat Rubin MN, Demaerschalk BM (2014) The use of telemedicine in the management of acute stroke. Neurosurg Focus 36(1):E4CrossRef Rubin MN, Demaerschalk BM (2014) The use of telemedicine in the management of acute stroke. Neurosurg Focus 36(1):E4CrossRef
Metadaten
Titel
Neurological update: dizziness
verfasst von
Diego Kaski
Publikationsdatum
04.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-09748-w

Weitere Artikel der Ausgabe 6/2020

Journal of Neurology 6/2020 Zur Ausgabe

Pioneers in Neurology

Rudolf Altschul (1901–1963)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.